11 research outputs found
PCV9 COST-EFFECTIVENESS ANALYSIS OF ALTEPLASE COMPARED WITH STREPTOKINASE AND ABSENCE OF THROMBOLYTICAL THERAPY FOR MYOCARDIAL INFARCTION
Get PDF
PCN6 ECONOMICAL EVALUATION OF RALTITREXED VERSUS FLUOROURACIL PLUS LEUCOVORIN (5-FU + LV) FOR TREATMENT OF ADVANCED COLORECTAL CANCER
No full textPCV26 FIRST RUSSIAN EXPERIENCE OF ASSESSING WILLINGNESS TO PAY: AVOIDING AMPUTATION IN CASE OF CRITICAL LIMB ISCHEMIA
No full textPCN20: COST MINIMIZATION ANALYSIS OF CEFEPIME VERSUS IMIPENEM-CILASTATINE IN CANCER PATIENTS WITH SHORT-DURATION FEBRILE NEUTROPENIA
No full textPCV8: COST-EFFECTIVENESS OF CLOPIDOGREL COMPARED WITH TICLOPIDINE IN THROMBOSIS PREVENTION: DECISION ANALYSIS TAKING INTO ACCOUNT SIDE-EFFECTS
No full textPCV2: COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL COMPARED WITH TICLOPIDINE IN THROMBOSIS PREVENTION
No full textPCHI3: PHARMACOECONOMICAL ANALYSIS OF UNFRACTIONATED HEPARIN VERSUS DALTEPARIN IN PATIENTS WITH MALIGNANCIES
No full text
